ACOG — Alpha Cognition Share News
0.000.00%
Last trade - 00:00- CA$120.37m
- CA$118.30m
Brief: Alpha Cognition Inc - Files Registration Statement For $25 Million Offering
Brief: Alpha Cognition Announces Completion Of $4.545 Million Convertible Note And Warrants Bridge Financing
Brief: Alpha Cognition Says On Track To Secure Financing For Continued Growth
Brief: Alpha Cognition Inc Says Applied To List Common Shares On Nasdaq Under Trading Symbol “Acog”
Brief: Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment
Brief: Alpha Cognition Announces FDA Acceptance Of New Drug Application For Mild-To-Moderate Alzheimer’S Disease
Brief: Alpha Cognition Announces Second Closing Of Private Placement And Continuation Of The Offering
Brief: Alpha Cognition Announces Fourth Quarter And Full Year 2022 Results
Brief: Alpha Cognition Announces Third Quarter 2022 Results And Provides Corporate Update
Brief: Alpha Cognition Announces Marketed Offering
Brief: Alpha Cognition Reports Qtrly Net Loss Of $0.05 Per Share
Brief: Alpha Cognition Announces Positive Topline Results From Bioequivalence Study With Alpha-1062 In Development For Alzheimer's Disease
Brief: Alpha Cognition Announces Results From Pivotal Study Of Alzheimer's Disease Treatment
Brief: Alpha Cognition Announces Positive Data From Pre-Clinical Studies And Discovery Of Gem Combinations With Potential For Neurodegenerative Disease Treatment
Brief: Alpha Cognition Inc - On Track And Plans To Release Data From Alpha-1062 Pivotal Trial During Q2 Of 2022
Brief: Alpha Cognition Reports Qtrly Net Loss Of $0.07 Per Share
Brief: Alpha Cognition Reports Change Of CFO
Brief: Alpha Cognition Announces Positive Neuroprotection Data From Pre-Clinical Study Of Alpha-1062
Brief: Alpha Cognition Announce Data From Pre-Clinical Study Of Alpha-1062 For Traumatic Brain Injury